[1]廖佳 熊青松 凌智瑜 殷跃辉.影 像学检查在心房颤动射频导管消融术的应用进展[J].心血管病学进展,2022,(1):33-37.[doi:10.16806/j.cnki.issn.1004-3934.2022.01.009]
 Imaging Examination in Radiofrequency Catheter Ablation of Atrial Fibrillation.[J].Advances in Cardiovascular Diseases,2022,(1):33-37.[doi:10.16806/j.cnki.issn.1004-3934.2022.01.009]
点击复制

影 像学检查在心房颤动射频导管消融术的应用进展()
分享到:

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2022年1期
页码:
33-37
栏目:
出版日期:
2022-01-25

文章信息/Info

作者:
廖佳 熊青松 凌智瑜 殷跃辉
(重庆医科大学附属第二医院心内科,重庆 400010)
Author(s):
Imaging Examination in Radiofrequency Catheter Ablation of Atrial Fibrillation
LIAO Jia,XIONG Qingsong,LING Zhiyu,YING Yuehui (Department of Cardiology,The Second Affiliated Hospital of Chongqing Medical University,Chongqing 400010,China)
关键词:
心房颤动射频导管消融术多层螺旋CT心脏磁共振成像心腔内超声
Keywords:
Atrial fibrillationRadiofrequency catheter ablationMultislice computed tomographyCardiac magnetic resonance imagingIntracardiac echocardiography
DOI:
10.16806/j.cnki.issn.1004-3934.2022.01.009
摘要:
射频导管消融术已成为临床心房颤动的一线治疗方案,充分的术前和术后评估对提高手术的成功率及减少并发症有重要价值。近年来,随着各类新的影像学方法的出现及原有影像学技术的不断发展,心房颤动消融的围手术期评估体系呈现多元化态势。熟悉及准确地运用影像学检查,在指导患者选择、术前准备及预后判断中起着不可替代的作用。
Abstract:
Radiofrequency catheter ablation has become the first-line treatment for atrial fibrillation in clinic,and adequate preoperative and postoperative evaluation is of great value in improv ing the success of surgery and reducing the complications. In recent years,with the emergence ofvarious new imaging methods and the continuous development of existing imaging techniques,the perioperative evaluation system of atrial fibrillation ablation has been diversified. Familiar and accurate use of imaging examination plays an irreplaceable role in guiding patient selection, preoperative preparation and prognosis judgment

参考文献/References:

[1] Beaser AD,Cifu AS. Management of patients with atrial fibrillation[J]. JAMA,2019,321(11):1100-1101.

[2] January CT,Wann LS,Calkins H,et al. 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation:a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons[J]. Circulation,2019,140(2):e125-e151.

[3] Hindricks G,Potpara T,Dagres N,et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery(EACTS):The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology(ESC) Developed with the special contribution of the European Heart Rhythm Association(EHRA) of the ESC[J]. Eur Heart J,2021,42(5):373-498.

[4] 何钗,杨英. 心脏磁共振在房颤患者左心房左心耳血栓检测中的应用进展[J]. 分子影像学杂志,2019,42(1):27-30.

[5] Spagnolo P,Giglio M,di Marco D,et al. Diagnosis of left atrial appendage thrombus in patients with atrial fibrillation:delayed contrast-enhanced cardiac CT[J]. Eur Radiol,2021,31(3):1236-1244.

[6] Kitkungvan D,Nabi F,Ghosn MG,et al. Detection of LA and LAA thrombus by CMR in patients referred for pulmonary vein isolation[J]. JACC Cardiovasc Imaging,2016,9(7):809-818.

[7] Zhu MR,Wang M,Ma XX,et al. The value of left atrial strain and strain rate in predicting left atrial appendage stasis in patients with nonvalvular atrial fibrillation[J]. Cardiol J,2018,25(1):87-96.

[8] Skowerski M,Wozniak-Skowerska I,Hoffmann A,et al. Pulmonary vein anatomy variants as a biomarker of atrial fibrillation-CT angiography evaluation[J]. BMC Cardiovasc Disord,2018,18(1):146.

[9] Istratoaie S,Ro?u R,Cismaru G,et al. The impact of pulmonary vein anatomy on the outcomes of catheter ablation for atrial fibrillation[J]. Medicina(Kaunas),2019,55(11):727.

[10] Kocyigit D,Yalcin MU,Gurses KM,et al. Pulmonary vein orientation is independently associated with outcomes following cryoballoon-based atrial fibrillation ablation[J]. J Cardiovasc Comput Tomogr,2018,12(4):281-285.

[11] Larsen JM,Deyell MW,Macle L,et al. Impact of left common pulmonary veins in the contact-force vs. Cryoballoon Atrial Fibrillation Ablation (CIRCA-DOSE) study[J]. J Cardiovasc Electrophysiol,2020 Jul 6. DOI:10.1111/jce.14652. Online ahead of print.

[12] Peng LQ,Yu JQ,Yang ZG,et al. Left atrial diverticula in patients referred for radiofrequency ablation of atrial fibrillation:assessment of prevalence and morphologic characteristics by dual-source computed tomography[J]. Circ Arrhythm Electrophysiol,2012,5(2):345-350.

[13] Schneider M,Morris DA,Pieske-Kraigher E,et al. Left atrial diverticulum—An unexpected finding in routine transesophageal echocardiography[J]. Echocardiography,2021,38(1):147-148.

[14] Dong J,Dickfeld T,Dalal D,et al. Initial experience in the use of integrated electroanatomic mapping with three -dimensional MR/CT images to guide catheter ablation of atrial fibrillation[J]. J Cardiovasc Electrophysiol,2006,17(5):459-466.

[15] 梁梅,郝应禄,杨明,等. 采用Cartosound零射线射频消融治疗心房颤动五例[J]. 中国心脏起搏与心电生理杂志,2018,32(4):411-412.

[16] Biermann J,Bode C,Asbach S. Intracardiac echocardiography during catheter-based ablation of atrial fibrillation[J]. Cardiol Res Pract,2012,2012:921746.

[17] Nakamura K,Naito S,Kaseno K,et al. Integration of intracardiac echocardiography and computed tomography during atrial fibrillation ablation:combining ultrasound contours obtained from the right atrium and ventricular outflow tract[J]. Int J Cardiol,2017,228:677-686.

[18] Rordorf R,Chieffo E,Savastano S,et al. Anatomical mapping for atrial fibrillation ablation:a head-to-head comparison of ultrasound-assisted reconstruction versus fast anatomical mapping[J]. Pacing Clin Electrophysiol,2015,38(2):187-195.

[19] Linhart M,Alarcon F,Borràs R,et al. Delayed gadolinium enhancement magnetic resonance imaging detected anatomic gap length in wide circumferential pulmonary vein ablation lesions is associated with recurrence of atrial fibrillation[J]. Circ Arrhythm Electrophysiol,2018,11(12):e006659.

[20] Fochler F,Yamaguchi T,Kheirkahan M,et al. Late gadolinium enhancement magnetic resonance imaging guided treatment of post-atrial fibrillation ablation recurrent arrhythmia[J]. Circ Arrhythm Electrophysiol,2019,12(8):e007174.

[21] Marrouche NF,Greene T,Dean JM,et al. Efficacy of LGE-MRI-guided fibrosis ablation versus conventional catheter ablation of atrial fibrillation:The DECAAFⅡtrial:study design[J]. J Cardiovasc Electrophysiol,2021,32(4):916-924.

[22] Yarlagadda B,Deneke T,Turagam M,et al. Temporal relationships between esophageal injury type and progression in patients undergoing atrial fibrillation catheter ablation[J]. Heart Rhythm,2019,16(2):204-212.

[23] Halbfass P,Lehmkuhl L,Foldyna B,et al. Correlation of magnetic resonance imaging and post-ablation endoscopy to detect oesophageal thermal injury in patients after atrial fibrillation ablation:MRI-EDEL-study[J]. Europace,2020,22(7):1009-1016.

[24] Marashly Q,Gopinath C,Baher A,et al. Late gadolinium enhancement magnetic resonance imaging evaluation of post-atrial fibrillation ablation esophageal thermal injury across the spectrum of severity[J]. J Am Heart Assoc,2021,10(7):e018924.

[25] Doppalapudi H,Yamada T,Kay GN. Complications during catheter ablation of atrial fibrillation:identification and prevention[J]. Heart Rhythm,2009,6(12 suppl):S18-S25.

[26] Ghaye B,Szapiro D,Dacher JN,et al. Percutaneous ablation for atrial fibrillation:the role of cross-sectional imaging[J]. Radiographics,2003?Oct;23 Spec No:S19-33;discussion S48-50.

[27] Ohana M,Bakouboula B,Labani A,et al. Imaging before and after catheter ablation of atrial fibrillation[J]. Diagn Interv Imaging,2015,96(11):1113-1123.

[28] Marrouche NF,Wilber D,Hindricks G,et al. Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation:the DECAAF study[J]. JAMA,2014,311(5):498-506.

[29] Kheirkhahan M,Baher A,Goldooz M,et al. Left atrial fibrosis progression detected by LGE-MRI after ablation of atrial fibrillation[J]. Pacing Clin Electrophysiol,2020,43(4):402-411.

[30] Khurram IM,Habibi M,Gucuk Ipek E,et al. Left atrial LGE and arrhythmia recurrence following pulmonary vein isolation for?paroxysmal and persistent AF[J]. JACC Cardiovasc Imaging,2016,9(2):142-148.

[31] Caixal G,Alarcón F,Althoff TF,et al. Accuracy of left atrial fibrosis detection with cardiac magnetic resonance:correlation of late gadolinium enhancement with endocardial voltage and conduction velocity[J]. Europace,2021,23(3):380-388.

[32] Cho KI,Kim BJ,Cho SH,et al. Epicardial fat thickness and free fatty acid level are predictors of acute ischemic stroke with atrial fibrillation[J]. J Cardiovasc Imaging,2018,26(2):65-74.

[33] Maeda M,Oba K,Yamaguchi S,et al. Usefulness of epicardial adipose tissue volume to predict recurrent atrial fibrillation after radiofrequency catheter ablation[J]. Am J Cardiol,2018,122(10):1694-1700.

[34] Sepehri Shamloo A,Dagres N,Dinov B,et al. Is epicardial fat tissue associated with atrial fibrillation recurrence after ablation? A systematic review and meta-analysis[J]. Int J Cardiol Heart Vasc,2019,22:132-138.

[35] Beyer C,Tokarska L,Stühlinger M,et al. Structural cardiac remodeling in atrial?fibrillation[J]. JACC Cardiovasc Imaging,2021,14(11):2199-2208.

[36] 牛海燕,田国祥,张敏郁,等. 三维超声心动图及斑点追踪成像评价左心房不同构型阵发性房颤患者左心房功能的临床研究[J]. 中国循证心血管医学杂志,2020,12(1):39-42.

[37] 贺鹏康,杨颖,范芳芳,等. 左心房顺应性参数与阵发性心房颤动射频消融术后复发率相关性分析[J]. 中国介入心脏病学杂志,2020,28(2):94-101.

[38] Soga F,Tanaka H,Mochizuki Y,et al. Combined assessment of left atrial volume parameters for predicting recurrence of atrial fibrillation following pulmonary vein isolation in patients with paroxysmal atrial fibrillation[J]. Echocardiography,2019,36(5):862-869.

[39] Nielsen AB,Skaarup KG,Lassen MCH,et al. Usefulness of left atrial speckle tracking echocardiography in predicting recurrence of atrial fibrillation after radiofrequency ablation:a systematic review and meta-analysis.[J]. Int J Cardiovasc Imaging,2020,36(7):1293-1309.

[40] Wen S,Indrabhinduwat M,Brady PA,et al. Post procedural peak left atrial contraction strain predicts recurrence of arrhythmia after catheter ablation of atrial fibrillation[J]. Cardiovasc Ultrasound,2021,19(1):22.

[41] Romanov A,Pokushalov E,Ponomarev D,et al. Pulmonary vein isolation with concomitant renal artery denervation is associated with reduction in both arterial blood pressure and atrial fibrillation burden:data from implantable cardiac monitor[J]. Cardiovasc Ther,2017,35(4). DOI:10.1111/1755-5922.12264.

相似文献/References:

[1]贺鹏康,周菁.心房颤动治疗新技术——冷冻球囊消融[J].心血管病学进展,2016,(1):1.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.001]
 HE Pengkang,ZHOU Jing.Cryoballoon Ablation, A Novel Technology for Atrial Fibrillation Treatment[J].Advances in Cardiovascular Diseases,2016,(1):1.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.001]
[2]都明辉,施海峰*,佟佳宾,等.心房颤动消融相关性无症状性脑缺血[J].心血管病学进展,2016,(1):3.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.002]
 DU Minghui,SHI Haifeng*,TONG Jiabin,et al.Silent Cerebral Ischemia Related to Atrial Fibrillation Ablation[J].Advances in Cardiovascular Diseases,2016,(1):3.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.002]
[3]郑环杰,综述,肖骅,等.心房颤动抗栓治疗研究进展[J].心血管病学进展,2016,(2):142.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.012]
 ZHENG Huanjie,XIAO Hua.Progress of Antithrombotic Therapy in Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(1):142.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.012]
[4]张清,综述,罗素新,等.新型Xa 因子抑制剂———依度沙班在心房颤动患者抗凝治疗中的研究进展[J].心血管病学进展,2016,(2):151.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.014]
 ZHANG Qing,LUO Suxin,TANG Jiong.Novel Factor Xa Inhibitors—Edoxaban in Prevention of Stroke in Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(1):151.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.014]
[5]胡红玲,综述,罗素新,等.预防非瓣膜性心房颤动性脑卒中的治疗新进展[J].心血管病学进展,2016,(3):250.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.009]
 HU Hongling,LUO Suxin.New Progress in the Treatment for Cerebral Apoplexy of Nonvalvular Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(1):250.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.009]
[6]王超,杨国澍,综述,等.关附甲素治疗心房颤动的研究进展[J].心血管病学进展,2016,(3):254.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.010]
 WANG Chao,YANG Guoshu,CAI Lin,et al.Research Progress of the Treatment of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(1):254.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.010]
[7]徐小东,综述,杨东辉,等.决奈达隆治疗心房颤动的现状及展望[J].心血管病学进展,2016,(4):368.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.011]
 XU Xiaodong,YANG Donghui.Status and Prospect of Dronedarone in Treating Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(1):368.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.011]
[8]张莎,储国俊,吴弘.经导管左心耳封堵术的临床应用进展[J].心血管病学进展,2015,(5):547.[doi:10.3969/j.issn.1004-3934.2015.05.006]
 ZHANG Sha,CHU Guojun,WU Hong.Clinial Application Advances in Left Atrial Appendage Closure[J].Advances in Cardiovascular Diseases,2015,(1):547.[doi:10.3969/j.issn.1004-3934.2015.05.006]
[9]汪俊,杨浩.心房颤动射频消融的术式演变[J].心血管病学进展,2015,(5):574.[doi:10.3969/j.issn.1004-3934.2015.05.013]
 WANG Jun,YANG Hao.Evolution of Radiofrequency Ablation of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2015,(1):574.[doi:10.3969/j.issn.1004-3934.2015.05.013]
[10]赵璐,苏立.心房颤动与离子通道重构研究进展[J].心血管病学进展,2015,(5):580.[doi:10.3969/j.issn.1004-3934.2015.05.014]
 ZHAO Lu,SU Li.Research Progress of Atrial Fibrillation and Ion Channel Remodeling[J].Advances in Cardiovascular Diseases,2015,(1):580.[doi:10.3969/j.issn.1004-3934.2015.05.014]
[11]颜如玉 赵海玉 张建武 彭健.心房颤动高功率短时程消融的临床应用进展[J].心血管病学进展,2021,(1):39.[doi:10.16806/j.cnki.issn.1004-3934.2021.01.000]
 YAN Ruyu,ZHAO Haiyu,ZHANG Jianwu,et al.Clinical Application of High-power and Short-term Ablation for Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2021,(1):39.[doi:10.16806/j.cnki.issn.1004-3934.2021.01.000]

更新日期/Last Update: 2022-02-17